BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 28818157)

  • 1. Tumor Response Evaluation Criteria: Standardization Ensures Success.
    Zaman MU; Fatima N; Sajid M
    J Coll Physicians Surg Pak; 2017 Jul; 27(7):389-391. PubMed ID: 28818157
    [No Abstract]   [Full Text] [Related]  

  • 2. Radiologic assessment of response to therapy: comparison of RECIST Versions 1.1 and 1.0.
    Chalian H; Töre HG; Horowitz JM; Salem R; Miller FH; Yaghmai V
    Radiographics; 2011; 31(7):2093-105. PubMed ID: 22084190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [New response evaluation criteria in solid tumours-revised RECIST guideline (version 1.1)].
    Watanabe H; Okada M; Kaji Y; Satouchi M; Sato Y; Yamabe Y; Onaya H; Endo M; Sone M; Arai Y
    Gan To Kagaku Ryoho; 2009 Dec; 36(13):2495-501. PubMed ID: 20009446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response criteria in oncologic imaging: review of traditional and new criteria.
    Tirkes T; Hollar MA; Tann M; Kohli MD; Akisik F; Sandrasegaran K
    Radiographics; 2013; 33(5):1323-41. PubMed ID: 24025927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiologic measurements of tumor response to treatment: practical approaches and limitations.
    Suzuki C; Jacobsson H; Hatschek T; Torkzad MR; Bodén K; Eriksson-Alm Y; Berg E; Fujii H; Kubo A; Blomqvist L
    Radiographics; 2008; 28(2):329-44. PubMed ID: 18349443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Invited commentary on American College of Radiology Appropriateness Criteria endometrial carcinoma.
    O'Malley R; Dighe MK
    Ultrasound Q; 2014 Mar; 30(1):29-31. PubMed ID: 24901776
    [No Abstract]   [Full Text] [Related]  

  • 7. [Activity, objective response, and WHO and RECIST (Response Evaluation Criteria In Solid Tumor) evaluation criteria].
    De Angelis V
    Suppl Tumori; 2004; 3(4):S7-9. PubMed ID: 15206198
    [No Abstract]   [Full Text] [Related]  

  • 8. Modified RECIST (mRECIST) assessment for hepatocellular carcinoma.
    Lencioni R; Llovet JM
    Semin Liver Dis; 2010 Feb; 30(1):52-60. PubMed ID: 20175033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. OARSI Clinical Trials Recommendations: Hip imaging in clinical trials in osteoarthritis.
    Gold GE; Cicuttini F; Crema MD; Eckstein F; Guermazi A; Kijowski R; Link TM; Maheu E; Martel-Pelletier J; Miller CG; Pelletier JP; Peterfy CG; Potter HG; Roemer FW; Hunter DJ
    Osteoarthritis Cartilage; 2015 May; 23(5):716-31. PubMed ID: 25952344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Tumor response evaluation].
    Watanabe H; Higashino T; Ohno Y; Takenaka D; Sugimura K
    Nihon Rinsho; 2002 May; 60 Suppl 5():322-8. PubMed ID: 12101681
    [No Abstract]   [Full Text] [Related]  

  • 11. The classification of traumatic brain injury (TBI) for targeted therapies.
    Povlishock JT
    J Neurotrauma; 2008 Jul; 25(7):717-8. PubMed ID: 18627251
    [No Abstract]   [Full Text] [Related]  

  • 12. OARSI Clinical Trials Recommendations: Knee imaging in clinical trials in osteoarthritis.
    Hunter DJ; Altman RD; Cicuttini F; Crema MD; Duryea J; Eckstein F; Guermazi A; Kijowski R; Link TM; Martel-Pelletier J; Miller CG; Mosher TJ; Ochoa-Albíztegui RE; Pelletier JP; Peterfy C; Raynauld JP; Roemer FW; Totterman SM; Gold GE
    Osteoarthritis Cartilage; 2015 May; 23(5):698-715. PubMed ID: 25952343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Why review answer criteria in solid tumors ?].
    Marotti M
    Rev Assoc Med Bras (1992); 2009; 55(4):369-71. PubMed ID: 19750296
    [No Abstract]   [Full Text] [Related]  

  • 14. RECIST revisited: a review of validation studies on tumour assessment.
    Therasse P; Eisenhauer EA; Verweij J
    Eur J Cancer; 2006 May; 42(8):1031-9. PubMed ID: 16616487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes research in cardiovascular imaging: report of a workshop sponsored by the National Heart, Lung, and Blood Institute.
    Douglas PS; Taylor A; Bild D; Bonow R; Greenland P; Lauer M; Peacock F; Udelson J
    J Cardiovasc Comput Tomogr; 2009; 3(4):212-23. PubMed ID: 19577208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ACR Appropriateness Criteria® pretreatment evaluation and follow-up of endometrial cancer.
    Lalwani N; Dubinsky T; Javitt MC; Gaffney DK; Glanc P; Elshaikh MA; Kim YB; Lee LJ; Pannu HK; Royal HD; Shipp TD; Siegel CL; Simpson L; Wahl AO; Wolfson AH; Zelop CM;
    Ultrasound Q; 2014 Mar; 30(1):21-8. PubMed ID: 24901775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response evaluation criteria in solid tumors (RECIST): new guidelines.
    Tsuchida Y; Therasse P
    Med Pediatr Oncol; 2001 Jul; 37(1):1-3. PubMed ID: 11466715
    [No Abstract]   [Full Text] [Related]  

  • 18. Should we be implementing untested guidelines?
    Goldberg HI
    Front Health Serv Manage; 1993; 10(1):45-7. PubMed ID: 10127904
    [No Abstract]   [Full Text] [Related]  

  • 19. SNM submits imaging endpoint comments to FDA.
    Clarke B; Merrill J
    J Nucl Med; 2012 Feb; 53(2):13N. PubMed ID: 22302969
    [No Abstract]   [Full Text] [Related]  

  • 20. Paratracheal lymph node dissection in cancer of the larynx, hypopharynx, and cervical esophagus: the need for guidelines.
    de Bree R; Leemans CR; Silver CE; Robbins KT; Rodrigo JP; Rinaldo A; Takes RP; Shaha AR; Medina JE; Suárez C; Ferlito A
    Head Neck; 2011 Jun; 33(6):912-6. PubMed ID: 20652978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.